These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 11165140)

  • 1. Biodistribution and antitumour efficacy of long-circulating N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin conjugates in nude mice.
    Shiah JG; Dvorák M; Kopecková P; Sun Y; Peterson CM; Kopecek J
    Eur J Cancer; 2001 Jan; 37(1):131-9. PubMed ID: 11165140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of the chemotherapeutic action of HPMA copolymer-bound doxorubicin in a solid tumor model of ovarian carcinoma.
    Minko T; Kopecková P; Kopecek J
    Int J Cancer; 2000 Apr; 86(1):108-17. PubMed ID: 10728603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination chemotherapy and photodynamic therapy of targetable N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin/mesochlorin e(6)-OV-TL 16 antibody immunoconjugates.
    Shiah JG; Sun Y; Kopecková P; Peterson CM; Straight RC; Kopecek J
    J Control Release; 2001 Jul; 74(1-3):249-53. PubMed ID: 11489502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biodistribution of free and N-(2-hydroxypropyl)methacrylamide copolymer-bound mesochlorin e(6) and adriamycin in nude mice bearing human ovarian carcinoma OVCAR-3 xenografts.
    Shiah JJ; Sun Y; Peterson CM; Kopecek J
    J Control Release; 1999 Aug; 61(1-2):145-57. PubMed ID: 10469911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor activity of N-(2-hydroxypropyl) methacrylamide copolymer-Mesochlorine e6 and adriamycin conjugates in combination treatments.
    Shiah JG; Sun Y; Peterson CM; Straight RC; Kopecek J
    Clin Cancer Res; 2000 Mar; 6(3):1008-15. PubMed ID: 10741728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of a multivalent galactoside ligand for selective targeting of HPMA copolymer-doxorubicin conjugates to human colon cancer cells.
    David A; Kopecková P; Minko T; Rubinstein A; Kopecek J
    Eur J Cancer; 2004 Jan; 40(1):148-57. PubMed ID: 14687799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPMA copolymer-doxorubicin conjugates: The effects of molecular weight and architecture on biodistribution and in vivo activity.
    Etrych T; Subr V; Strohalm J; Sírová M; Ríhová B; Ulbrich K
    J Control Release; 2012 Dec; 164(3):346-54. PubMed ID: 22759979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-molecular weight HPMA copolymer-adriamycin conjugates.
    Dvorák M; Kopecková P; Kopecek J
    J Control Release; 1999 Aug; 60(2-3):321-32. PubMed ID: 10425337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gamma scintigraphy of a 123I-labelled N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin conjugate containing galactosamine following intravenous administration to nude mice bearing hepatic human colon carcinoma.
    Pimm MV; Perkins AC; Strohalm J; Ulbrich K; Duncan R
    J Drug Target; 1996; 3(5):385-90. PubMed ID: 8866657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The structure of polymer carriers controls the efficacy of the experimental combination treatment of tumors with HPMA copolymer conjugates carrying doxorubicin and docetaxel.
    Šírová M; Strohalm J; Chytil P; Lidický O; Tomala J; Říhová B; Etrych T
    J Control Release; 2017 Jan; 246():1-11. PubMed ID: 27940304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of long-circulating, backbone degradable HPMA copolymer-doxorubicin conjugates and evaluation of molecular-weight-dependent antitumor efficacy.
    Pan H; Sima M; Yang J; Kopeček J
    Macromol Biosci; 2013 Feb; 13(2):155-60. PubMed ID: 23339052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pronounced Cellular Uptake of Pirarubicin versus That of Other Anthracyclines: Comparison of HPMA Copolymer Conjugates of Pirarubicin and Doxorubicin.
    Nakamura H; Koziolová E; Chytil P; Tsukigawa K; Fang J; Haratake M; Ulbrich K; Etrych T; Maeda H
    Mol Pharm; 2016 Dec; 13(12):4106-4115. PubMed ID: 27934482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel α
    Wang F; Li L; Sun W; Li L; Liu Y; Huang Y; Zhou Z
    J Drug Target; 2018 Mar; 26(3):231-241. PubMed ID: 28792244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of PK1 and doxorubicin in experimental colon tumor models with differing responses to PK1.
    Loadman PM; Bibby MC; Double JA; Al-Shakhaa WM; Duncan R
    Clin Cancer Res; 1999 Nov; 5(11):3682-8. PubMed ID: 10589787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poly(ethylene glycol)-poly(ester-carbonate) block copolymers carrying PEG-peptidyl-doxorubicin pendant side chains: synthesis and evaluation as anticancer conjugates.
    Andersson L; Davies J; Duncan R; Ferruti P; Ford J; Kneller S; Mendichi R; Pasut G; Schiavon O; Summerford C; Tirk A; Veronese FM; Vincenzi V; Wu G
    Biomacromolecules; 2005; 6(2):914-26. PubMed ID: 15762660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cooperativity between free and N-(2-hydroxypropyl) methacrylamide copolymer bound adriamycin and meso-chlorin e6 monoethylene diamine induced photodynamic therapy in human epithelial ovarian carcinoma in vitro.
    Lu JM; Peterson CM; Guo-Shiah J; Gu ZW; Peterson CA; Straight RC; Kopecek J
    Int J Oncol; 1999 Jul; 15(1):5-16. PubMed ID: 10375588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination chemotherapy and photodynamic therapy with N-(2-hydroxypropyl) methacrylamide copolymer-bound anticancer drugs inhibit human ovarian carcinoma heterotransplanted in nude mice.
    Peterson CM; Lu JM; Sun Y; Peterson CA; Shiah JG; Straight RC; Kopecek J
    Cancer Res; 1996 Sep; 56(17):3980-5. PubMed ID: 8752167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel doxorubicin-glucuronide prodrug DOX-GA3 for tumour-selective chemotherapy: distribution and efficacy in experimental human ovarian cancer.
    Houba PH; Boven E; van der Meulen-Muileman IH; Leenders RG; Scheeren JW; Pinedo HM; Haisma HJ
    Br J Cancer; 2001 Feb; 84(4):550-7. PubMed ID: 11207053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymer conjugates of the highly potent cytostatic drug 2-pyrrolinodoxorubicin.
    Studenovsky M; Ulbrich K; Ibrahimova M; Rihova B
    Eur J Pharm Sci; 2011 Jan; 42(1-2):156-63. PubMed ID: 21075206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of primary and metastatic tumors in mice by E-selectin-targeted polymer-drug conjugates.
    Shamay Y; Raviv L; Golan M; Voronov E; Apte RN; David A
    J Control Release; 2015 Nov; 217():102-12. PubMed ID: 26297207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.